Allergy News and Research

RSS

The term allergy encompasses a wide range of conditions; it is not a disease in itself. In 1906 Clemens von Pirquet was the first to describe allergies as a changed or altered reaction of the immune system in response to exposure to foreign proteins. These days the term allergy – medically termed hypersensitivity, signifies an exaggerated reaction to foreign substances.

Researchers find that hay fever and allergies make migraines worse

People with migraine who also battle allergies and hay fever (rhinitis) endure a more severe form of headaches than their peers who struggle with migraine, but aren't affected by the seasonal or year-round sniffles, according to researchers from the University of Cincinnati, Montefiore Medical Center and the Albert Einstein College of Medicine of Yeshiva University and Vedanta Research.

26 Nov 2013

Purlife inks deal with Canada-based auto warranty company

Neutra Corp. (OTCBB: NTRR), a growing provider of all-natural wellness solutions, is proud to announce that its partner, Purlife, has signed a deal with one of Canada's largest automotive warranty companies to make its revolutionary Drivepur Protection System available to a network of 1,200 car dealerships.

26 Nov 2013

Expanding access to health insurance may not inflate ICU usage in Massachusetts, shows study

A multi-institution study led by researchers at the Perelman School of Medicine at the University of Pennsylvania has found that increasing the number of insured patients is not associated with higher intensive care unit (ICU) usage in Massachusetts.

26 Nov 2013

Icahn School of Medicine receives $2.7M to investigate narrow pathway targeted immune therapy

The National Institutes of Health has awarded a research team at the Icahn School of Medicine at Mount Sinai $2.7 million to study systemic treatments for patients with moderate to severe atopic dermatitis (AD), also known as eczema.

26 Nov 2013

People with food allergy more likely to be murdered than to die from severe reaction

A person with a food allergy is more likely to be murdered than to die from a severe reaction, according to a new study.

25 Nov 2013

Scientists find link between airborne allergies and risk of blood cancers in women

A team of scientists looking into the interplay of the immune system and cancer have found a link between a history of airborne allergies - in particular to plants, grass and trees - with risk of blood cancers in women.

25 Nov 2013

First molecular test developed to detect eosinophilic esophagitis

Researchers at Cincinnati Children's Hospital Medical Center have developed the first molecular test to diagnose eosinophilic esophagitis, a chronic upper gastrointestinal disorder. The incidence of EoE has skyrocketed since it was first characterized two decades ago.

22 Nov 2013

Research: Introducing solid food with breast milk could reduce food allergies in babies

Introducing solid food with breast milk after the 17th week of birth could reduce food allergies in babies, according to University of Southampton research.

20 Nov 2013

NIAID awards $4.4M grant to study unknown gene function in bacteria that cause plague, brucellosis

The National Institute of Allergy and Infectious Diseases has awarded the University of Chicago $4.4 million over five years to study genes of unknown function in bacteria that cause plague and brucellosis.

20 Nov 2013

Atopix recruits first patient in OC459 Phase 2 trial for treatment of atopic dermatitis

Atopix Therapeutics Ltd, a biopharmaceutical company developing innovative CRTH2 antagonists for allergic disease, announced the recruitment of the first patient in a six month Phase 2 clinical trial of its lead compound OC459 in moderate-to-severe atopic dermatitis (eczema).

19 Nov 2013

Genetic mutations in parasite cause over 100 million cases of malaria annually in Africa

Researchers at Case Western Reserve University and Cleveland Clinic Lerner Research Institute have discovered recent genetic mutations in a parasite that causes over 100 million cases of malaria annually-changes that may render tens of millions of Africans who had been considered resistant, susceptible to infection.

16 Nov 2013

Intelliject to be recognized with George DiDomizio Industry Award

The Institute for Safe Medication Practices has announced that this year's George DiDomizio Industry Award is being presented to Intelliject, Inc. for pioneering advances in drug/device combination products with the Auvi-Q epinephrine auto-injector (also known as Allerject™ in Canada). Auvi-Q is the first auto-injector with audio as well as visual cues for the emergency treatment of life-threatening allergic reactions.

16 Nov 2013

Kaiser Permanente to open doors to brand new specialty center in Lone Tree, Colorado

After years of planning, construction and preparation, Kaiser Permanente will open the doors to a brand new specialty center in Lone Tree on December 2nd. This is the largest construction project and the most significant addition to the health plan's brick-and-mortar presence in Colorado in nearly a decade.

15 Nov 2013

Dermalogix awarded SBIR Phase II grant to develop topical drug candidate for atopic dermatitis

Signum Dermalogix, Inc. announced that the National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded the company a Small Business Innovation Research Phase II grant totaling $1.6 million for the development of a topical drug candidate for atopic dermatitis.

15 Nov 2013

Severe sepsis mortality rates decrease over the past 20 years

A recent study from Boston University School of Medicine and Boston Medical Center shows a significant decrease in severe sepsis mortality rates over the past 20 years. Looking at data from patients with severe sepsis enrolled in clinical trials, researchers found that in-hospital mortality rates decreased from 47 percent between 1991 and 1995 to 29 percent between 2006 and 2009, a time period when no new pharmacological treatments were developed for severe sepsis.

14 Nov 2013

Flublok influenza vaccine for the 2013-14 season now available

Protein Sciences Corporation, the manufacturer of Flublok, the new, pure influenza vaccine containing no egg proteins, influenza virus, preservatives (e.g., thimerosal), antibiotics, gelatin or latex, announced today that doses for the 2013-14 season have been released by the FDA and are now available.

14 Nov 2013

Researchers discover powerful mechanism that keeps white blood cells from going rogue

The immune system is a double-edged sword. While its primary role is to fight infections, it can also become overactive, leading to problems like allergies and autoimmune diseases.

13 Nov 2013

Dermatologist offers tips for healthy hair when using hair treatments

While coloring your hair is a common beauty treatment, the process can leave your hair dry and brittle. Fortunately, dermatologists, who are experts in the care of the skin, hair and nails, offer tips for coloring and perming your hair while keeping it healthy.

13 Nov 2013

Index predicts asthma in high-risk preschool children

Researchers have shown that the modified Asthma Predictive Index has high predictive value for future asthma development, when applied in the first 3 years of life.

12 Nov 2013

ED visits associated with OTC pediatric cough cold medicines in children decline

A new study, "Cough and Cold Medication Adverse Events After Market Withdrawal and Labeling Revision," shows that emergency department visits associated with over-the-counter pediatric cough cold medicines in children age 3 and younger have declined following voluntary industry labeling initiatives specifically designed to improve safe use in this age.

12 Nov 2013

Allergy News and Research

Further Reading

Researchers find that hay fever and allergies make migraines worse

Purlife inks deal with Canada-based auto warranty company

Expanding access to health insurance may not inflate ICU usage in Massachusetts, shows study

Icahn School of Medicine receives $2.7M to investigate narrow pathway targeted immune therapy

People with food allergy more likely to be murdered than to die from severe reaction

Scientists find link between airborne allergies and risk of blood cancers in women

First molecular test developed to detect eosinophilic esophagitis

Research: Introducing solid food with breast milk could reduce food allergies in babies

NIAID awards $4.4M grant to study unknown gene function in bacteria that cause plague, brucellosis

Atopix recruits first patient in OC459 Phase 2 trial for treatment of atopic dermatitis

Genetic mutations in parasite cause over 100 million cases of malaria annually in Africa

Intelliject to be recognized with George DiDomizio Industry Award

Kaiser Permanente to open doors to brand new specialty center in Lone Tree, Colorado

Dermalogix awarded SBIR Phase II grant to develop topical drug candidate for atopic dermatitis

Severe sepsis mortality rates decrease over the past 20 years

Flublok influenza vaccine for the 2013-14 season now available

Researchers discover powerful mechanism that keeps white blood cells from going rogue

Dermatologist offers tips for healthy hair when using hair treatments

Index predicts asthma in high-risk preschool children

ED visits associated with OTC pediatric cough cold medicines in children decline

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News